Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP11B1 | P15538 | 3/20 | 0.66 |
| ▸ | CYP11B2 | P19099 | 3/20 | 0.66 |
| ▸ | CYP1A1 | P04798 | 1/20 | 0.54 |
| ▸ | CYP1B1 | Q16678 | 1/20 | 0.54 |
| ▸ | IDO1 | P14902 | 5/20 | 0.50 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.50 |
| ▸ | HPGDS | O60760 | 1/20 | 0.47 |
| ▸ | LTA4H | P09960 | 1/20 | 0.46 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.45 |
| ▸ | CYP17A1 | P05093 | 1/20 | 0.45 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.45 |
| ▸ | CTRC | Q99895 | 1/20 | 0.43 |
| ▸ | SIRT2 | Q8IXJ6 | 3/20 | 0.41 |
| ▸ | NLN | Q9BYT8 | 2/20 | 0.40 |
| ▸ | HRH3 | Q9Y5N1 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19397457 | 0.97 | CYP11B1 (0.62) | CYP11B1CYP11B2CYP1A1CYP1B1IDO1 | |
| SCHEMBL19397567 | 0.96 | CYP11B1 (0.61) | CYP11B1CYP11B2CYP1A1CYP1B1IDO1 | |
| SCHEMBL19397350 | 0.90 | IDO1 (0.54) | CYP11B1CYP11B2IDO1CYP3A4HPGDS | |
| SCHEMBL19397452 | 0.90 | IDO1 (0.54) | CYP11B1CYP11B2IDO1CYP3A4HPGDS | |
| SCHEMBL19397562 | 0.87 | IDO1 (0.51) | CYP11B1CYP11B2IDO1CYP3A4HPGDS | |
| SCHEMBL19397453 | 0.83 | CYP3A4 (0.54) | CYP11B1CYP11B2IDO1CYP3A4HPGDS | |
| SCHEMBL19397343 | 0.82 | CYP11B1 (0.46) | CYP11B1CYP11B2IDO1CYP3A4HPGDS | |
| SCHEMBL19397456 | 0.81 | SCN9A (0.46) | CYP11B1CYP11B2IDO1CYP3A4HPGDS | |
| SCHEMBL19397576 | 0.81 | CYP3A4 (0.51) | CYP11B1CYP11B2IDO1CYP3A4HPGDS | |
| SCHEMBL2369049 | 0.80 | CYP11B1 (1.00) | CYP11B1CYP11B2IDO1CYP3A4HPGDS |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10580995-B2 | Compounds for organic electroluminescent components and organic electroluminescent devices using the same | E-RAY OPTOELECTRONICS TECHNOLOGY CO., LTD. (TW) | 2020-03-03 | — | — | US | disclosed |
| US-20170279054-A1 | COMPOUNDS FOR ORGANIC ELECTROLUMINESCENT COMPONENTS AND ORGANIC ELECTROLUMINESCENT DEVICES USING THE SAME | E-RAY OPTOELECTRONICS TECHNOLOGY CO., LTD. (TW) | 2017-09-28 | — | — | US | disclosed |
| US-20170279054-A1 | COMPOUNDS FOR ORGANIC ELECTROLUMINESCENT COMPONENTS AND ORGANIC ELECTROLUMINESCENT DEVICES USING THE SAME | E-RAY OPTOELECTRONICS TECHNOLOGY CO., LTD. (TW) | 2017-09-28 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10580995-B2 | Compounds for organic electroluminescent components and organic electroluminescent devices using the same | C1S, AOC2, L1CAM | CYP11B1 323/4885CYP11B2 389/4885CYP1A1 83/4885 |
| US-20170279054-A1 | COMPOUNDS FOR ORGANIC ELECTROLUMINESCENT COMPONENTS AND ORGANIC ELECTROLUMINESCENT DEVICES USING THE SAME | L1CAM, C1S, F10 | CYP11B1 799/4885CYP11B2 1013/4885CYP1A1 241/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.